$CNMD News

CONMED Corporation 2026 Q2 - Results - Earnings Call Presentation

Piper Sandler Reiterates Neutral on Conmed, Raises Price Target to $45

Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46

CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript

CONMED (CNMD) Surges After Q2 Earnings Beat and Raised EPS Outlook

Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est

CONMED Says AirSeal Robotic Solution Is Now Indicated For Use With Intuitive’s 8 mm Hex Cannulas Used As Part Of Intuitive Da Vinci 5 Platform

CONMED (CNMD) Stock Trades Up, Here Is Why

CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest

BMO Capital Initiates Coverage of CONMED (CNMD) with Market Perform Recommendation

BMO Capital Initiates Coverage On Conmed with Market Perform Rating, Announces Price Target of $36

CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious

CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026

Why CONMED (CNMD) Shares Are Falling Today

B of A Securities Downgrades CONMED (CNMD)

CONMED Lagging Medtech Peers as Growth Slows, BofA Securities Says

B of A Securities Downgrades Conmed to Underperform, Maintains Price Target to $40

CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer

CONMED Appoints John E. Gallagher CFO, Effective July 15, Succeeding Todd Garner

Q1 Earnings Outperformers: CONMED (NYSE:CNMD) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks